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osmotic pressure as well as redox poten-
tial and pH.[1] Sudden overdoses of ions 
in the cytosol or other intracellular com-
partments often induce programmed 
cell death. High amounts of cytosolic 
calcium, for example, induce apoptosis,[2] 
and ferroptosis is triggered by an over-
dose of lysosomal iron.[3] Controlled 
introduction of ions into certain cellular 
compartments would allow for an under-
standing of how ions influence cellular 
processes in these compartments. At 
the same time, it bears high therapeutic 
potential, specifically the induction of 
programmed cell death. However, due to 
the profound importance of ion concen-
trations, cells maintain their ion balance 
very carefully. Complex procedures ensure 
uptake, storage, and release of the neces-
sary amounts of ions and strictly prevent 
external manipulation of ion levels.[1a,4] To 
overcome these regulatory mechanisms, 
small molecules, such as ionophores or 
inhibitors of cellular ion channels, have 
been used previously.[5] While they allow for manipulation of ion 
homeostasis to a certain extent, they often also interact with off-
target molecules obstructing the investigation of the influence 
Ion homeostasis is essential for cellular survival, and elevated concentrations 
of specific ions are used to start distinct forms of programmed cell death. 
However, investigating the influence of certain ions on cells in a controlled way 
has been hampered due to the tight regulation of ion import by cells. Here, it 
is shown that lipid-coated iron-based metal–organic framework nanoparticles 
are able to deliver and release high amounts of iron ions into cells. While high 
concentrations of iron often trigger ferroptosis, here, the released iron induces 
pyroptosis, a form of cell death involving the immune system. The iron release 
occurs only in slightly acidic extracellular environments restricting cell death to 
cells in acidic microenvironments and allowing for external control. The release 
mechanism is based on endocytosis facilitated by the lipid-coating followed 
by degradation of the nanoparticle in the lysosome via cysteine-mediated 
reduction, which is enhanced in slightly acidic extracellular environment. Thus, 
a new functionality of hybrid nanoparticles is demonstrated, which uses their 
nanoarchitecture to facilitate controlled ion delivery into cells. Based on the 
selectivity for acidic microenvironments, the described nanoparticles may also 
be used for immunotherapy: the nanoparticles may directly affect the primary 
tumor and the induced pyroptosis activates the immune system.
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Ions are important signals for cells, and maintenance of 
their intracellular concentration is essential for survival. They 
activate signaling cascades and regulate enzyme activity and 
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of ions. Moreover, their molecular structure makes it difficult to 
dissect the effect of the ion concentration from other reactive 
groups in the  molecule. Direct,  controlled intracellular intro-
duction of ions would enable a study of the mechanisms of ion-
triggered cellular processes on an atomistic level eliminating 
any obstructing effects of mediator molecules.
Hybrid metal–organic framework (MOF) nanoparticles offer 
an option to overcome the challenge of direct and controlled ion 
delivery.[6] They consist of high amounts of ions coordinated to 
organic linker molecules and the specific ion and organic linker 
can be chosen from a plethora of building blocks to match the 
requirements of the application.[7] Thus, they can be built from 
the ions that are to be released in the cells. The nanoscale size 
of MOF nanoparticles facilitates cellular internalization. To 
prevent cellular recognition of the ions on the surface of MOF 
nanoparticles and to overcome subsequent cellular regulation 
mechanisms, the nanoparticle surface can be functionalized, 
for example, with polymers[6c,8] or lipid coatings.[9] Finally, their 
structure and chemical stability can, in principle, be designed 
to meet the desired degradation conditions and kinetics, which 
would control the location and kinetics of ion release. An 
example would be degradation under the reductive milieu of 
the lysosome or by chelation agents.[9b] Pore size with respect to, 
for example, the chelating molecule will then control the reac-
tion kinetics. A large pore size combined with a relatively small 
degrading molecule that can access all interaction sites will, in 
most cases, enable sudden release. Hence, the specific hybrid 
nanoarchitecture of MOF nanoparticles combined with their 
tailorable surface functionalization renders them a promising 
candidate for stealth ion transport into cells followed by sudden 
release of high amounts of ions under controlled conditions.
In this study, we show that lipid-coated MIL-100(Fe) MOF 
nanoparticles,[10] consisting of iron (Fe3+) and trimesic acid, are 
able to introduce high amounts of iron ions into cells. The lipid 
coating facilitates cellular uptake via endocytosis. Acidification 
of the extracellular pH subsequently leads to intracellular deg-
radation of MOF nanoparticles and release of iron followed by 
cell death and lysis. When studying this process in detail, we 
found that degradation of MOF nanoparticles triggers pyrop-
tosis, an inflammatory form of programmed cell death.[11] Its 
dependence on the extracellular pH provides an external trigger 
for pyroptosis induction. This shows how delivery of ion over-
doses can lead to unforeseen effects, such as the activation of 
pyroptosis in this particular case. Similar effects may be found 
when the principle of ion delivery via controlled degradation of 
lipid-coated MOF nanoparticles is applied to other ions.
MIL-100(Fe) nanoparticles were synthesized as reported 
in literature (for characterization and detailed synthesis, see 
Supporting Information).[12] To facilitate their cellular uptake via 
endocytosis, the nanoparticles were coated with 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC) (see Figure  1a; Figure S1, 
Supporting Information). Coating was performed by mixing the 
MIL-100(Fe) nanoparticles with DOPC-liposomes and employing 
lipid fusion as previously described.[9b,13] Successful coating was 
confirmed with nitrogen-sorption measurements and infrared 
spectroscopy (Figure  1b; Figure S2, Supporting Information). 
The resulting DOPC-coated MIL-100(Fe) nanoparticles (denoted 
here as Lip-MOF) had a hydrodynamic radius of 250  nm as 
determined by dynamic light scattering (Figure  1c). Electron 
microscopy and X-ray diffraction indicated that the properties 
of MOF nanoparticles are conserved upon the lipid coating 
(Figure 1d,e; Figures S3 and S4, Supporting Information).
Next, we investigated the effect of Lip-MOFs on cells. We 
loaded them with the dye calcein prior to liposome coating 
such that the fluorophore is quenched by the MOFs and only 
becomes visible upon the degradation of the MOFs. The cal-
cein-loaded Lip-MOFs were brought in contact with HeLa cells 
(Figure 2a; see also Movie S1, Supporting Information). Directly 
after incubation, the particles are not visible since the calcein is 
still quenched within the nanoparticles. About 40 h after incu-
bation, calcein was visible, indicating that the Lip-MOF have 
degraded. Shortly afterwards, we observed a sudden spread of 
the calcein dye all over the cell followed by a burst and defla-
tion of the entire cell. An MTT test 72 h after incubation con-
firmed the observed toxicity of the Lip-MOF with an IC50 of 
≈3 µg mL–1 (Figure 2b, green squares). Strikingly, this toxicity 
was strongly dependent on the extracellular pH: the extracel-
lular pH of the medium covering metabolizing HeLa cells 
decreases over time.[14] The described cell death was observed 
in experiments without exchange of the medium resulting in a 
decreased pH value. When the pH was kept constant at pH 7.4 
by daily exchange of the medium, cell viability was not affected 
significantly (Figure  2b, orange circles). The toxicity of Lip-
MOF could be restored by daily changes of medium at pH 7.2 
(Figure 2b, red triangles). To test whether this effect was really 
due to iron delivery and not based on trimesic acid, we added 
Tiron to the medium (Figure 2b, blue triangles). Tiron chelates 
Fe3+ as present in Lip-MOF and will transport the ions across 
the cellular membranes reducing the local, intracellular iron 
concentration. Addition of Tiron inhibits the effect of Lip-MOF 
confirming the high amount of delivered iron as the cause of 
the observed cell burst. Iron oxide nanoparticles, however, did 
not induce this effect (see Figure S5, Supporting Information), 
nor did MIL-88A nanoparticles consisting of Fe3+ and fumaric 
acid.[9b,13b] Hence, cell lysis is due to intracellular iron delivery 
of Lip-MOF controlled by the extracellular pH. This is an 
entirely new effect of MOF nanoparticles.
To gain a better understanding of this unusual lytic effect, we 
first studied the cellular internalization mechanism. Cellular 
uptake of Lip-MOF was quantified 30  min after incubation 
via inductively coupled plasma optical emission spectrometry 
(ICP-OES) (Figure  2c). Comparison between the uptake at 
37 and 4  °C shows a significant reduction in nanoparticle 
uptake at reduced temperatures. This suggests that energy-
dependent endocytosis may be the main uptake pathway for 
Lip-MOF as reported for MOF nanoparticles in literature.[15] 
Uncoated MIL-100(Fe) on the contrary did not show any toxicity 
to cells (Figure S6, Supporting Information) and its uptake was 
not significantly reduced at 4  °C, that is, endocytosis was not 
the main uptake pathway. This suggests that the lipid bilayer 
mediates efficient uptake via endocytosis as the first important 
step for the pH-dependent toxicity of Lip-MOFs. Further inves-
tigation on the uptake mechanism was performed by inhibition 
of different endocytosis pathways with Dynasore, Cytocha-
lasin D, and Filipin, respectively. The results suggest clathrin-
mediated endocytosis to be the main uptake pathway as 
Dynasore showed the strongest reduction in iron uptake meas-
ured by ICP-OES (Figure S7, Supporting Information). This is 
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in accordance with literature.[15] Lysosomal markers colocalized 
with the  distinct spots of the dye that were observed about 40 h 
after cell incubation with Lip-MOFs (Figure 2d; Figure S8, Sup-
porting Information). Thus, 40 h after incubation, the Lip-MOF 
were internalized via endocytosis and reached the acidic lyso-
some. In the lysosome, the nanoparticles are degraded and the 
dye is no longer quenched. This leads to the observed fluores-
cence of the dye after 40 h. Some of the dye is still contained 
within the lysosomes and visible as puncta. Shortly afterwards, 
the fluorescence spreads throughout the cell, indicating degra-
dation of the lysosomes. Lysosomal degradation of the Lip-MOF 
was also confirmed by immediate decomposition in artificial 
lysosomal fluid (ALF), which simulates the lysosomal environ-
ment. Quantitative UV–vis measurements of an iron marker 
revealed within errors a complete decomposition of the Lip-
MOF after only 1 h in ALF (Figure S9, Supporting  Information). 
In simulated body fluid, which simulates the environment in 
the blood rather than within lysosomes, no decomposition of 
the Lip-MOF could be detected (Figure S9, Supporting Infor-
mation). This decomposition of the Lip-MOF in the lysosome 
is a crucial part of its toxicity. Accordingly, whenever a burst of 
cells was observed, it was preceded by calcein fluorescence in 
the lysosome as a reporter of Lip-MOF. At constant extracel-
lular pH 7.4, when cell death is not induced, this calcein fluores-
cence in the lysosome was not detected (Figure S10, Supporting 
Information).
ALF contains citric acid, which causes degradation of the 
Lip-MOF into its building blocks, that is, iron ions and trimesic 
acid. The role of citric acid in the ALF is to simulate lysosomal 
enzyme activity. In order to find the origin of the lysosomal 
degradation of Lip-MOF, we investigated the influence of 
lysosomal enzymes. A direct degradation of the Lip-MOF by 
Adv. Mater. 2020, 32, 1907267
Figure 1. Synthesis and characterization of Lip-MOF nanoparticles. a) Synthesis route. b) IR spectroscopy reveals successful lipid coating. IR spectra 
of Lip-MOF nanoparticles (red), unfunctionalized MIL-100(Fe) nanoparticles (black), and pure DOPC (blue). The inset shows a magnification of the 
significant aliphatic C–H stretching vibrations present in DOPC and Lip-MOF. c) Size determination of Lip-MOFs via dynamic light scattering of 
unfunctionalized MIL-100(Fe) nanoparticles (black) and Lip-MOF (red) in DPBS. Lip-MOF show a slight increase in average size compared to uncoated 
MOFs and possess a homogeneous size distribution around 250 nm. d,e) SEM images of uncoated (d) and lipid-coated MIL-100(Fe) (e) nanoparticles 
at 150 000× magnification.
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enzymes is very unlikely due to their speci-
ficity and steric hindrances. Accordingly, 
none of the tested inhibitors of various lyso-
somal hydrolases had an effect on the toxicity 
of Lip-MOF (Figure S11, Supporting Informa-
tion). Also, the acidic pH of the lysosome can 
be excluded as the reason for degradation, 
since addition of HCl does not degrade the 
MOF nanoparticles (Figure S12, Supporting 
Information). However, lysosomes contain a 
high amount of cysteines[16] and the reduc-
tive milieu created by cysteines destroys 
MIL-100(Fe) as shown in Figure 3a. The reac-
tion kinetics displayed in Figure  3b (cf. also 
Figures S13 and S14, Supporting Informa-
tion) exhibits a delay of the process by at least 
5  min. Any enzyme-driven reaction in the 
lysosome relying on cysteines will be faster. 
Thus, the delay allows for the maintenance of 
reactions that rely on cysteines, such as scav-
enging of reactive oxygen species. Further-
more, it suggests that the reaction can only 
take place in the excess of cysteines. Accord-
ingly, the amount of lysosomal cysteines and 
thus its reductive potential should influence 
the degradation of Lip-MOF in cells. Indeed, 
addition of 5  × 10−3 m N-acetyl-cysteine 
(Figure 3c) or GSH (Figure S15a, Supporting 
Information) into the medium enhanced the 
efficiency of Lip-MOF to induce cell death. 
In addition, ZnSO4 reduced the effect that 
Lip-MOF had on cells (Figure S15b, Sup-
porting Information), most likely due to Zn2+ 
binding to cysteines and thereby reducing the 
amount of active cysteines.[17] The depend-
ence on lysosomal cysteines and their reduc-
tive potential explains the dependence of 
the effect on extracellular pH: the reductive 
Adv. Mater. 2020, 32, 1907267
Figure 2. Uptake and cell viability of Lip-MOF in cells. a) Time-lapse images of Lip-MOF on 
HeLa cells. Overlay of bright-field (grayscale) and fluorescence (cyan) images at 0, 37.5, and 
75 h after incubation of HeLa cells with calcein-loaded Lip-MOF. Over time, Lip-MOF degrade 
as visualized by the increase in calcein fluorescence (cyan). Subsequently, cell lysis is observed. 
A schematic representation of cell shape at the respective time points is shown on top of each 
image. Scale bar: 100 µm. b) Cell viability after Lip-MOF incubation for 72 h measured via a 
MTT assay. Incubation without medium exchange (green squares) leads to cell death. Medium 
exchange to pH 7.4 (orange circles) every 24 h 
restores cell viability. Medium exchange to pH 7.2 
(red triangles) every 24 h did not prevent cell death. 
Addition of the iron-chelating compound Tiron (blue 
triangles) after 24 h restores cell viability. The mean 
values and standard deviations represent the average 
of biological triplicates. Each data set is normalized to 
cells growing under the same conditions but without 
exposure to Lip-MOF. The gray background is a guide 
to the eye indicating no significant toxicity. c) Iron 
uptake of HeLa cells measured by ICP-OES after incu-
bation of Lip-MOF and uncoated MOF nanoparticles 
at 37 and 4 °C. Values are normalized to iron uptake 
for Lip-MOF at 37 °C. The negative control is without 
MOF addition. d) Confocal microscopy images of 
HeLa cells incubated with Atto647N-loaded Lip-MOF 
after 40  h incubation without medium exchange. 
Lysosomes (cyan) and nanoparticles (magenta) are 
colocalized as shown in white in the merged image 
on the right. Lysosomes were labeled by transiently 
transfecting the cells with CellLight Lysosomes-GFP. 
Scale bar: 25 µm.
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potential of HeLa cells as measured by MTT assays was already 
14% higher after only 24  h at pH 7.2 as compared to pH 7.4. 
Also, the Raman signature of lysosomes and lipid vesicles in 
cells (Figure S16, Supporting Information) differs between the 
two pH values and confirms changes in the chemical composi-
tion revealing, among other things, a higher cysteine content 
and corresponding reductive potential at lower pH. At pH 7.2, 
the spectra showed more signal in the range of aliphatic C–S 
stretch vibrations[18] (630–790 cm, Figure S17 and Table S1, Sup-
porting Information) most likely resulting from cysteines.
Next, we sought to investigate the origin of the cell bursting. 
Knowing that lysosomal degradation of Lip-MOF and the 
associated iron delivery is essential for this effect, we investigated 
how the high amount of iron ions generated by the Lip-MOF 
degradation leads to cell death. High amounts of lysosomal iron 
have been shown to induce ferroptosis.[3] However, as discussed 
above, cysteine and glutathione (Figure  3c; Figure S15a, Sup-
porting Information) had the opposite effect, although they are 
known inhibitors of ferroptosis.[19] Liproxstatin, a very potent 
inhibitor of ferroptosis,[20] had no effect on Lip-MOF-induced 
cell death (Figure S15c, Supporting Information), suggesting 
that Lip-MOFs do not induce ferroptosis. Instead, z-YVAD-FMK, 
a selective caspase inhibitor[21] for pyroptosis-inducing caspases 
1, 4, and 5, mitigates the effect, indicating pyroptosis as the cell 
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Figure 3. Chemical degradation of MOF nanoparticles and pyroptosis. a) Absorbance spectra of cysteine and trimesic acid, which is released during 
degradation of MOF nanoparticles by cysteines as a function of time. b) Absorbance of trimesic acid at 245 nm as a function of incubation time. 
c,d) MTT assay of HeLa cells incubated with Lip-MOF without medium exchange in the presence of: c) cysteine and d) caspase inhibitor z-YVAD-FMK 
(blue, circle). e,f) Anti-GSDMD Western blot of control cells (Lane 1) and cells incubated with Lip-MOF (Lane 2) showing a reduction to 25% of full 
length GSDMD (53 kDa). g) Anti-IL-1β ELISA assay of medium from HeLa cells incubated with Lip-MOF and phosphate-buffered saline as a control 
showing the release of interleukin-1β after Lip-MOF incubation as a sign for pyroptosis induced by Lip-MOF. The mean values and standard deviations 
represent the average of biological triplicates.
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death mechanism (Figure  3c)–especially in combination with 
the observed cell swelling and lysis. A similar reduction of the 
effect was observed in the presence of the osmolyte betaine, 
which has been shown to inhibit pyroptosis[22] (Figure S15d, Sup-
porting Information). Pyroptosis is mediated by caspase-induced 
gasdermin cleavage followed by gasdermin pore formation in 
the cell membrane.[23] These gasdermin pores perforate the 
cell membrane inducing IL-1β release and cell swelling until 
they burst.[24] Indeed, we found a significant reduction of full-
length gasdermin D (GSDMD) in Western blots of Lip-MOF-
treated cells (Figure 3d,f; Figure S18, Supporting Information). 
The length of the GSDMD cleavage product suggests caspase-3 
activity, which has been reported to induce pyroptosis via 
GSDME activation.[25] We also observe IL-1β released into the 
medium. Thus, Lip-MOF induces pyroptosis after degradation 
by cysteines in cells with a high reductive potential at slightly 
acidic pH. Iron has been reported to trigger pyroptosis medi-
ated by reactive oxygen species (ROS) production.[26] However, 
we did not observe any ROS (Figure S19, Supporting Infor-
mation), nor did the ROS inhibitors cysteine or Liproxstatin 
(Figure  3c; Figure S15c, Supporting Information) inhibit the 
effect, suggesting that ROS does not play a role in Lip-MOF-
induced pyroptosis. Another possible pathway for the observed 
pyroptosis could be via the BCL family members BAX[27] and 
BCL-2.[28] But neither inhibition of BCL-2 nor activation of BAX 
had any impact on the efficiency of pyroptosis induction by Lip-
MOF (Figure S20, Supporting Information).[29] Thus, the effect 
is supposedly independent of BAX and BCL-2 concentrations. 
To test whether the effect found for HeLa cells applies to other 
cell types as well, we performed experiments with several other 
cell lines. We found the pyroptosis-inducing effect of Lip-MOF 
being present also in A431 and MCF7 cells, but not in A549 
cells (Figure S21a–c, Supporting Information), suggesting that 
A549 cells are more tolerant toward high concentrations of 
lysosomal iron. Non-tumorigenic breast cells MCF-10A were 
significantly less affected (Figure S21d, Supporting Informa-
tion) than breast cancer cells MCF-7 (Figure S21a, Supporting 
Information). Finally, we tested the effect of Lip-MOF on mac-
rophages. Macrophages have been reported to show activation 
in response to other iron formulations.[30] Moreover, they are 
present in tumor environments and internalize the majority of 
administered nanoparticles.[31] Upon incubation with Lip-MOF, 
macrophages clearly showed pyroptosis. The observed pyrop-
tosis was dependent on extracellular pH similarly to HeLa cells 
(Figure S22, Supporting Information). Thus, a possible immune 
stimulus will not be hampered, if most of the administered 
nanoparticles are taken up by macrophages in the tumor envi-
ronment rather than by tumor cells. These results encourage 
future studies on the underlying molecular mechanism as a 
basis for future successful translation in vivo.
In conclusion, we have demonstrated that the synergistic 
combination of lipids and MOF nanoparticles exploits the 
advantageous properties of each system to create a controllable 
platform for intracellular iron delivery. The lipid coating facili-
tates stealth endolysosomal uptake and the MOF nano particles 
release their building blocks into the cell. Together, they over-
come cellular regulation and deliver high amounts of iron ions 
into the cell. This process is controlled by the extracellular 
pH via the intracellular reductive potential. Ultimately, pyrop-
tosis is induced by caspase activation followed by GSDMD 
cleavage and cell lysis (Figure 4). This unprecedented property 
of lipid-coated MOF nanoparticles may be used in the future 
for investigations of the effects of ion overdoses. Based on 
the tunability of MOF nanoparticles, the degradation kinetics, 
amount of released ions, and the specific type of released ion 
may be varied and investigated. This controlled ion delivery to 
cells in spatially confined microenvironments may pave the 
way for further nanomaterials with applications based on this 
Adv. Mater. 2020, 32, 1907267
Figure 4. Uptake of Lip-MOF nanoparticles leads to pyroptosis of cells in acidic environments. The proposed uptake mechanism of MOF nanoparticles 
and triggered signaling pathways: 1) Uptake via clathrin-mediated endocytosis. 2) Transfer to lysosomes. 3) pH-dependent reduction and disassembly 
of MOFs by reducing agents like cysteines. 4) Degradation of Lip-MOF triggers lysosomal rupture and pyroptosis. Pyroptosis is mediated by caspase 
activation, which triggers gasdermin activation and interleukin-1β-release resulting in cell swelling and lysis.
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property. As an example, Lip-MOFs and similar nanostructures 
may be applied in immunotherapy for attacking tumor cells in 
the acidic tumor environment directly via pyroptosis and at the 
same time eliciting an immune response.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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